

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.59207493 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.88941218 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.88941218 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.88941218 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.88941218 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.88941218 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.88941218 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.72802294 |
| 9 | detection of other organism (GO:0098543) | 4.74735369 |
| 10 | immunoglobulin mediated immune response (GO:0016064) | 4.62376959 |
| 11 | respiratory burst (GO:0045730) | 4.51171741 |
| 12 | response to peptidoglycan (GO:0032494) | 4.50228902 |
| 13 | granulocyte activation (GO:0036230) | 4.49758308 |
| 14 | detection of bacterium (GO:0016045) | 4.45357096 |
| 15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.43657084 |
| 16 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.42764763 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 4.42409561 |
| 18 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 4.35336831 |
| 19 | positive regulation of interferon-alpha production (GO:0032727) | 4.34581928 |
| 20 | neutrophil activation (GO:0042119) | 4.34441800 |
| 21 | detection of external biotic stimulus (GO:0098581) | 4.27432131 |
| 22 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.13603787 |
| 23 | regulation of interferon-alpha production (GO:0032647) | 4.07733953 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 4.06780498 |
| 25 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.98506037 |
| 26 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.93680305 |
| 27 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.91664408 |
| 28 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.87356134 |
| 29 | cellular extravasation (GO:0045123) | 3.86348272 |
| 30 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.83571850 |
| 31 | detection of biotic stimulus (GO:0009595) | 3.79316379 |
| 32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.78805588 |
| 33 | response to host immune response (GO:0052572) | 3.78805588 |
| 34 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.78713062 |
| 35 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.74834942 |
| 36 | positive regulation of mast cell activation (GO:0033005) | 3.72731770 |
| 37 | positive regulation of macrophage cytokine production (GO:0060907) | 3.72555790 |
| 38 | positive regulation of antigen processing and presentation (GO:0002579) | 3.71101930 |
| 39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.70752309 |
| 40 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.69498187 |
| 41 | superoxide anion generation (GO:0042554) | 3.66982210 |
| 42 | myeloid cell activation involved in immune response (GO:0002275) | 3.65112692 |
| 43 | germinal center formation (GO:0002467) | 3.59829691 |
| 44 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.57934555 |
| 45 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.54423556 |
| 46 | cellular response to zinc ion (GO:0071294) | 3.52704379 |
| 47 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.50811485 |
| 48 | negative regulation of cell killing (GO:0031342) | 3.50811485 |
| 49 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.50024038 |
| 50 | regulation of mononuclear cell migration (GO:0071675) | 3.50015782 |
| 51 | reactive oxygen species biosynthetic process (GO:1903409) | 3.49545239 |
| 52 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.49313688 |
| 53 | microglial cell activation (GO:0001774) | 3.49182783 |
| 54 | response to muramyl dipeptide (GO:0032495) | 3.47387792 |
| 55 | eosinophil chemotaxis (GO:0048245) | 3.46077977 |
| 56 | negative regulation of interleukin-17 production (GO:0032700) | 3.46023816 |
| 57 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.45256947 |
| 58 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.44068508 |
| 59 | negative regulation of T cell mediated immunity (GO:0002710) | 3.41336982 |
| 60 | positive regulation of mast cell degranulation (GO:0043306) | 3.40113985 |
| 61 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.40113985 |
| 62 | B cell mediated immunity (GO:0019724) | 3.39786648 |
| 63 | response to interleukin-15 (GO:0070672) | 3.38473695 |
| 64 | myeloid dendritic cell differentiation (GO:0043011) | 3.35855874 |
| 65 | response to host (GO:0075136) | 3.35401801 |
| 66 | response to host defenses (GO:0052200) | 3.35401801 |
| 67 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.35401801 |
| 68 | regulation of cholesterol storage (GO:0010885) | 3.34691745 |
| 69 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.34669838 |
| 70 | type I interferon signaling pathway (GO:0060337) | 3.31102952 |
| 71 | cellular response to type I interferon (GO:0071357) | 3.31102952 |
| 72 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.31066794 |
| 73 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.30621814 |
| 74 | natural killer cell mediated immunity (GO:0002228) | 3.30621814 |
| 75 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.30424152 |
| 76 | myeloid dendritic cell activation (GO:0001773) | 3.29623862 |
| 77 | response to type I interferon (GO:0034340) | 3.28794340 |
| 78 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.27650900 |
| 79 | regulation of mast cell degranulation (GO:0043304) | 3.26442634 |
| 80 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.26370958 |
| 81 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.22035006 |
| 82 | wound healing, spreading of epidermal cells (GO:0035313) | 3.21921596 |
| 83 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.21338544 |
| 84 | macrophage activation (GO:0042116) | 3.19615576 |
| 85 | regulation of mast cell activation (GO:0033003) | 3.16357594 |
| 86 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.15985095 |
| 87 | positive regulation of interferon-beta production (GO:0032728) | 3.14823844 |
| 88 | regulation of T cell tolerance induction (GO:0002664) | 3.14014588 |
| 89 | eosinophil migration (GO:0072677) | 3.12953100 |
| 90 | regulation of B cell differentiation (GO:0045577) | 3.12234817 |
| 91 | response to protozoan (GO:0001562) | 3.11708058 |
| 92 | leukocyte aggregation (GO:0070486) | 3.11399019 |
| 93 | regulation of tolerance induction (GO:0002643) | 3.10445755 |
| 94 | regulation of antigen processing and presentation (GO:0002577) | 3.08388416 |
| 95 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.08297041 |
| 96 | monocyte chemotaxis (GO:0002548) | 3.07792761 |
| 97 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.07334951 |
| 98 | regulation of macrophage cytokine production (GO:0010935) | 3.07069064 |
| 99 | phagocytosis, recognition (GO:0006910) | 3.05987570 |
| 100 | cellular response to interleukin-15 (GO:0071350) | 3.04915028 |
| 101 | leukocyte mediated cytotoxicity (GO:0001909) | 3.02981360 |
| 102 | T cell migration (GO:0072678) | 3.01768882 |
| 103 | leukocyte degranulation (GO:0043299) | 3.01123506 |
| 104 | neutrophil chemotaxis (GO:0030593) | 3.01116496 |
| 105 | myeloid leukocyte mediated immunity (GO:0002444) | 3.00592101 |
| 106 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.00376369 |
| 107 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.00024731 |
| 108 | myeloid leukocyte activation (GO:0002274) | 2.99357861 |
| 109 | B cell receptor signaling pathway (GO:0050853) | 2.98873052 |
| 110 | positive regulation of B cell differentiation (GO:0045579) | 2.98180357 |
| 111 | defense response to protozoan (GO:0042832) | 2.97053286 |
| 112 | low-density lipoprotein particle clearance (GO:0034383) | 2.96948853 |
| 113 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.96627502 |
| 114 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.96065595 |
| 115 | neutrophil mediated immunity (GO:0002446) | 2.95206122 |
| 116 | positive regulation of interleukin-12 production (GO:0032735) | 2.95184063 |
| 117 | leukocyte cell-cell adhesion (GO:0007159) | 2.94003448 |
| 118 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.93290633 |
| 119 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.93290633 |
| 120 | neutrophil migration (GO:1990266) | 2.92712448 |
| 121 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.92122115 |
| 122 | phagosome maturation (GO:0090382) | 2.92071577 |
| 123 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.91118327 |
| 124 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.91118327 |
| 125 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.90258237 |
| 126 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.89968036 |
| 127 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.89607743 |
| 128 | negative regulation of interleukin-6 production (GO:0032715) | 2.89364495 |
| 129 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.88949923 |
| 130 | regulation of regulated secretory pathway (GO:1903305) | 2.88935936 |
| 131 | positive regulation of leukocyte degranulation (GO:0043302) | 2.88734794 |
| 132 | negative regulation of innate immune response (GO:0045824) | 2.87406513 |
| 133 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.85158738 |
| 134 | negative regulation of interleukin-12 production (GO:0032695) | 2.84893483 |
| 135 | regulation of chemokine biosynthetic process (GO:0045073) | 2.84524191 |
| 136 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.82546774 |
| 137 | regulation of leukocyte degranulation (GO:0043300) | 2.82451193 |
| 138 | detection of molecule of bacterial origin (GO:0032490) | 2.82013034 |
| 139 | T-helper 1 type immune response (GO:0042088) | 2.80147567 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.78612674 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.76989131 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.55546946 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.49994312 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.14880585 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.99909062 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.69100275 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.61616263 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.54195356 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.37774230 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.37171661 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.08275707 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.01322420 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.89410395 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.85458127 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.77648880 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.63423942 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.42087255 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.29974341 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.23617356 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.22130112 |
| 22 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.12843539 |
| 23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.12561671 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.00858449 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.93731998 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.89842856 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.86157699 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 1.81131182 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80451312 |
| 30 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.77593792 |
| 31 | MYC_22102868_ChIP-Seq_BL_Human | 1.77449023 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77370706 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.75756527 |
| 34 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.75222272 |
| 35 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67665026 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.66243187 |
| 37 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.65338447 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.61748866 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.56856476 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55105780 |
| 41 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.53189011 |
| 42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48712285 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47027912 |
| 44 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.45398601 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.42838381 |
| 46 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37978217 |
| 47 | MYB_26560356_Chip-Seq_TH1_Human | 1.33276606 |
| 48 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.32491433 |
| 49 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.30223781 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.29329069 |
| 51 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29302153 |
| 52 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28426766 |
| 53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27718862 |
| 54 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26879826 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21217941 |
| 56 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.19231398 |
| 57 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17905812 |
| 58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14219973 |
| 59 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.13560106 |
| 60 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13322421 |
| 61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12282340 |
| 62 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12073108 |
| 63 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11832678 |
| 64 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11773287 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11622766 |
| 66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06089359 |
| 67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04253343 |
| 68 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.03295393 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02720208 |
| 70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02599062 |
| 71 | UTX_26944678_Chip-Seq_JUKART_Human | 1.02510033 |
| 72 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00802451 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99908985 |
| 74 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98807445 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98565545 |
| 76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98314926 |
| 77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97880747 |
| 78 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96640397 |
| 79 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96640397 |
| 80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94213549 |
| 81 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93056081 |
| 82 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90874919 |
| 83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90764970 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89704566 |
| 85 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89569897 |
| 86 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.85112060 |
| 87 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.82785710 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 0.81344273 |
| 89 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80737593 |
| 90 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.78999099 |
| 91 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.77239575 |
| 92 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76413880 |
| 93 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.75630076 |
| 94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75474778 |
| 95 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.75276331 |
| 96 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.74827182 |
| 97 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.74790001 |
| 98 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.74610296 |
| 99 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73814325 |
| 100 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73614005 |
| 101 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.73349951 |
| 102 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.73349951 |
| 103 | GATA2_19941826_ChIP-Seq_K562_Human | 0.73155620 |
| 104 | KDM2B_26808549_Chip-Seq_K562_Human | 0.72648453 |
| 105 | CJUN_26792858_Chip-Seq_BT549_Human | 0.72252513 |
| 106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.71880547 |
| 107 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.69732613 |
| 108 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69260510 |
| 109 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.69178655 |
| 110 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.68130079 |
| 111 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.67975744 |
| 112 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.67722705 |
| 113 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67157719 |
| 114 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.66910112 |
| 115 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.65792408 |
| 116 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.64539547 |
| 117 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.64056397 |
| 118 | GATA1_19941826_ChIP-Seq_K562_Human | 0.64018741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.80198696 |
| 2 | MP0003436_decreased_susceptibility_to | 3.89046430 |
| 3 | MP0003303_peritoneal_inflammation | 3.77470778 |
| 4 | MP0006082_CNS_inflammation | 3.56744133 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.47046255 |
| 6 | MP0002419_abnormal_innate_immunity | 3.41323297 |
| 7 | MP0009785_altered_susceptibility_to | 3.24473742 |
| 8 | * MP0005000_abnormal_immune_tolerance | 3.20830194 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.94165400 |
| 10 | * MP0005025_abnormal_response_to | 2.89692066 |
| 11 | MP0005671_abnormal_response_to | 2.87990641 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.79561433 |
| 13 | MP0004510_myositis | 2.76656873 |
| 14 | MP0001790_abnormal_immune_system | 2.69552931 |
| 15 | MP0005387_immune_system_phenotype | 2.69552931 |
| 16 | MP0003724_increased_susceptibility_to | 2.68047469 |
| 17 | MP0000685_abnormal_immune_system | 2.56147301 |
| 18 | * MP0002723_abnormal_immune_serum | 2.48367086 |
| 19 | MP0001800_abnormal_humoral_immune | 2.46310465 |
| 20 | * MP0001819_abnormal_immune_cell | 2.34752321 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.32012097 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.17376249 |
| 23 | MP0002405_respiratory_system_inflammati | 2.16739475 |
| 24 | MP0003448_altered_tumor_morphology | 2.02616913 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.01287914 |
| 26 | MP0001853_heart_inflammation | 2.00809945 |
| 27 | MP0003172_abnormal_lysosome_physiology | 1.99496474 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.92687243 |
| 29 | MP0004947_skin_inflammation | 1.90506502 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.88263550 |
| 31 | MP0005451_abnormal_body_composition | 1.79041155 |
| 32 | MP0003075_altered_response_to | 1.72056601 |
| 33 | MP0002998_abnormal_bone_remodeling | 1.69992247 |
| 34 | MP0005310_abnormal_salivary_gland | 1.68391055 |
| 35 | MP0009764_decreased_sensitivity_to | 1.65630124 |
| 36 | MP0003690_abnormal_glial_cell | 1.63376129 |
| 37 | * MP0000716_abnormal_immune_system | 1.61913104 |
| 38 | MP0008469_abnormal_protein_level | 1.59986418 |
| 39 | MP0000343_altered_response_to | 1.57915486 |
| 40 | MP0002006_tumorigenesis | 1.56598984 |
| 41 | MP0000569_abnormal_digit_pigmentation | 1.56007340 |
| 42 | MP0000858_altered_metastatic_potential | 1.55947034 |
| 43 | MP0009840_abnormal_foam_cell | 1.52919352 |
| 44 | MP0005166_decreased_susceptibility_to | 1.52287855 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.51336391 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.44313936 |
| 47 | * MP0002398_abnormal_bone_marrow | 1.44003155 |
| 48 | MP0001851_eye_inflammation | 1.41279909 |
| 49 | MP0005257_abnormal_intraocular_pressure | 1.34583457 |
| 50 | MP0000604_amyloidosis | 1.29037723 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.27565954 |
| 52 | * MP0002429_abnormal_blood_cell | 1.27420228 |
| 53 | MP0010386_abnormal_urinary_bladder | 1.26781131 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.26110915 |
| 55 | MP0002277_abnormal_respiratory_mucosa | 1.25206395 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.25051605 |
| 57 | MP0009278_abnormal_bone_marrow | 1.21744919 |
| 58 | MP0008004_abnormal_stomach_pH | 1.21237639 |
| 59 | MP0002722_abnormal_immune_system | 1.18673029 |
| 60 | MP0003828_pulmonary_edema | 1.16360415 |
| 61 | MP0004782_abnormal_surfactant_physiolog | 1.15601264 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.13853090 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.13853090 |
| 64 | MP0003566_abnormal_cell_adhesion | 1.10077897 |
| 65 | MP0005174_abnormal_tail_pigmentation | 1.08377226 |
| 66 | MP0002396_abnormal_hematopoietic_system | 1.06856240 |
| 67 | MP0002933_joint_inflammation | 1.06618082 |
| 68 | MP0000703_abnormal_thymus_morphology | 1.06337844 |
| 69 | MP0004381_abnormal_hair_follicle | 1.03956947 |
| 70 | MP0002166_altered_tumor_susceptibility | 1.02161255 |
| 71 | MP0010307_abnormal_tumor_latency | 1.00934817 |
| 72 | MP0002254_reproductive_system_inflammat | 0.99647056 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 0.94949150 |
| 74 | MP0005390_skeleton_phenotype | 0.92914219 |
| 75 | MP0003705_abnormal_hypodermis_morpholog | 0.91687031 |
| 76 | MP0003806_abnormal_nucleotide_metabolis | 0.91454633 |
| 77 | MP0004130_abnormal_muscle_cell | 0.91355642 |
| 78 | MP0005076_abnormal_cell_differentiation | 0.90797674 |
| 79 | MP0009763_increased_sensitivity_to | 0.90620135 |
| 80 | MP0005164_abnormal_response_to | 0.90581570 |
| 81 | MP0000371_diluted_coat_color | 0.88327628 |
| 82 | MP0003183_abnormal_peptide_metabolism | 0.88035133 |
| 83 | MP0003186_abnormal_redox_activity | 0.86319880 |
| 84 | MP0002138_abnormal_hepatobiliary_system | 0.85386155 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 0.80282824 |
| 86 | MP0000920_abnormal_myelination | 0.79723606 |
| 87 | MP0002332_abnormal_exercise_endurance | 0.78760111 |
| 88 | MP0000465_gastrointestinal_hemorrhage | 0.78255749 |
| 89 | MP0002090_abnormal_vision | 0.76984958 |
| 90 | MP0003795_abnormal_bone_structure | 0.75972765 |
| 91 | MP0008260_abnormal_autophagy | 0.75382863 |
| 92 | MP0000249_abnormal_blood_vessel | 0.74414348 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.74347129 |
| 94 | MP0001958_emphysema | 0.72905828 |
| 95 | MP0001986_abnormal_taste_sensitivity | 0.71221527 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.68812734 |
| 97 | MP0001873_stomach_inflammation | 0.68268062 |
| 98 | MP0003866_abnormal_defecation | 0.68250736 |
| 99 | MP0003763_abnormal_thymus_physiology | 0.67639652 |
| 100 | MP0003045_fibrosis | 0.66926932 |
| 101 | MP0008874_decreased_physiological_sensi | 0.65593398 |
| 102 | MP0003091_abnormal_cell_migration | 0.64288737 |
| 103 | MP0001663_abnormal_digestive_system | 0.63426358 |
| 104 | MP0003279_aneurysm | 0.63205331 |
| 105 | MP0004883_abnormal_blood_vessel | 0.62479233 |
| 106 | MP0003329_amyloid_beta_deposits | 0.61085911 |
| 107 | MP0000767_abnormal_smooth_muscle | 0.58174061 |
| 108 | MP0006054_spinal_hemorrhage | 0.55912657 |
| 109 | MP0000490_abnormal_crypts_of | 0.55744925 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 0.55219214 |
| 111 | MP0005319_abnormal_enzyme/_coenzyme | 0.54837088 |
| 112 | MP0004808_abnormal_hematopoietic_stem | 0.53206211 |
| 113 | MP0000015_abnormal_ear_pigmentation | 0.52146102 |
| 114 | MP0004185_abnormal_adipocyte_glucose | 0.51931349 |
| 115 | MP0002132_abnormal_respiratory_system | 0.51234807 |
| 116 | MP0003221_abnormal_cardiomyocyte_apopto | 0.50395306 |
| 117 | MP0002877_abnormal_melanocyte_morpholog | 0.50088411 |
| 118 | MP0005075_abnormal_melanosome_morpholog | 0.49339944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.56020403 |
| 2 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.20898453 |
| 3 | Eczematoid dermatitis (HP:0000976) | 7.20841937 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.63544925 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.52488781 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 5.24492974 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 5.21355600 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 4.77133591 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.37182525 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.37182525 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 4.37182525 |
| 12 | Gingivitis (HP:0000230) | 4.35200047 |
| 13 | Recurrent skin infections (HP:0001581) | 4.30798956 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.10767007 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.04052316 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 4.03193141 |
| 17 | Obstructive lung disease (HP:0006536) | 4.03193141 |
| 18 | Myositis (HP:0100614) | 3.80395936 |
| 19 | Orchitis (HP:0100796) | 3.67208691 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.58867226 |
| 21 | Optic neuritis (HP:0100653) | 3.58867226 |
| 22 | Axonal loss (HP:0003447) | 3.53644324 |
| 23 | Dysostosis multiplex (HP:0000943) | 3.50840955 |
| 24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.47790950 |
| 25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.47247400 |
| 26 | Encephalitis (HP:0002383) | 3.46343480 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 3.46216182 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.38637694 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.38637694 |
| 30 | Stomatitis (HP:0010280) | 3.34230682 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 3.29406940 |
| 32 | Interstitial pulmonary disease (HP:0006530) | 3.25038727 |
| 33 | Recurrent viral infections (HP:0004429) | 3.20725020 |
| 34 | Myocardial infarction (HP:0001658) | 3.19719981 |
| 35 | Periodontitis (HP:0000704) | 3.16721884 |
| 36 | Increased IgE level (HP:0003212) | 3.15387066 |
| 37 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.08977633 |
| 38 | Vasculitis (HP:0002633) | 3.08686982 |
| 39 | Disinhibition (HP:0000734) | 3.07728173 |
| 40 | Loss of speech (HP:0002371) | 3.03186927 |
| 41 | Cellulitis (HP:0100658) | 3.02738075 |
| 42 | Chest pain (HP:0100749) | 2.93629079 |
| 43 | Mucopolysacchariduria (HP:0008155) | 2.92307040 |
| 44 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.92307040 |
| 45 | Amyloidosis (HP:0011034) | 2.90841803 |
| 46 | Basal ganglia calcification (HP:0002135) | 2.88319501 |
| 47 | Episodic fever (HP:0001954) | 2.78565936 |
| 48 | Meningitis (HP:0001287) | 2.73116939 |
| 49 | Urticaria (HP:0001025) | 2.72531555 |
| 50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.72082744 |
| 51 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.72082744 |
| 52 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.72082744 |
| 53 | Joint hemorrhage (HP:0005261) | 2.63300452 |
| 54 | Anorexia (HP:0002039) | 2.62707068 |
| 55 | Agnosia (HP:0010524) | 2.61970193 |
| 56 | Pulmonary embolism (HP:0002204) | 2.58964107 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.51238881 |
| 58 | Arterial thrombosis (HP:0004420) | 2.50739287 |
| 59 | Leukocytosis (HP:0001974) | 2.50325907 |
| 60 | Hematochezia (HP:0002573) | 2.50162998 |
| 61 | Hepatosplenomegaly (HP:0001433) | 2.49494071 |
| 62 | Hemoptysis (HP:0002105) | 2.49029637 |
| 63 | Pustule (HP:0200039) | 2.48663360 |
| 64 | Osteomyelitis (HP:0002754) | 2.45291416 |
| 65 | Spontaneous hematomas (HP:0007420) | 2.45229141 |
| 66 | Gangrene (HP:0100758) | 2.45219524 |
| 67 | Peritonitis (HP:0002586) | 2.43371337 |
| 68 | Gastrointestinal inflammation (HP:0004386) | 2.41928206 |
| 69 | Abnormality of T cell number (HP:0011839) | 2.37307321 |
| 70 | Thick nail (HP:0001805) | 2.34879343 |
| 71 | Abnormality of the pleura (HP:0002103) | 2.32807343 |
| 72 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.32627248 |
| 73 | Increased IgM level (HP:0003496) | 2.32020898 |
| 74 | Gingival bleeding (HP:0000225) | 2.30804234 |
| 75 | T lymphocytopenia (HP:0005403) | 2.29645710 |
| 76 | Glomerulonephritis (HP:0000099) | 2.29240524 |
| 77 | Abnormality of T cells (HP:0002843) | 2.28361368 |
| 78 | Increased serum ferritin (HP:0003281) | 2.27775943 |
| 79 | Recurrent pneumonia (HP:0006532) | 2.26598500 |
| 80 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.26162431 |
| 81 | Panhypogammaglobulinemia (HP:0003139) | 2.25982243 |
| 82 | Granulocytopenia (HP:0001913) | 2.20751050 |
| 83 | Hypochromic anemia (HP:0001931) | 2.19275047 |
| 84 | Abnormality of the endocardium (HP:0004306) | 2.15887506 |
| 85 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.14512973 |
| 86 | Osteolytic defects of the hand bones (HP:0009699) | 2.14512973 |
| 87 | Premature loss of primary teeth (HP:0006323) | 2.12897320 |
| 88 | Hypochromic microcytic anemia (HP:0004840) | 2.11759767 |
| 89 | Hypergammaglobulinemia (HP:0010702) | 2.09836224 |
| 90 | Vertigo (HP:0002321) | 2.09456995 |
| 91 | Keratoconjunctivitis sicca (HP:0001097) | 2.09114095 |
| 92 | Abnormality of the peritoneum (HP:0002585) | 2.08985955 |
| 93 | Prostate neoplasm (HP:0100787) | 2.08464622 |
| 94 | Polyneuropathy (HP:0001271) | 2.07947052 |
| 95 | Chronic otitis media (HP:0000389) | 2.06329769 |
| 96 | Colitis (HP:0002583) | 2.05285981 |
| 97 | Glomerulopathy (HP:0100820) | 2.05168211 |
| 98 | Gastrointestinal infarctions (HP:0005244) | 2.05073748 |
| 99 | Abnormality of iron homeostasis (HP:0011031) | 2.01554822 |
| 100 | Recurrent lower respiratory tract infections (HP:0002783) | 2.00768768 |
| 101 | Epistaxis (HP:0000421) | 2.00623697 |
| 102 | Abnormality of the lumbar spine (HP:0100712) | 2.00600853 |
| 103 | Cheilitis (HP:0100825) | 1.99672593 |
| 104 | Lymphopenia (HP:0001888) | 1.98700985 |
| 105 | Acne (HP:0001061) | 1.98567279 |
| 106 | Petechiae (HP:0000967) | 1.98205524 |
| 107 | Peripheral demyelination (HP:0011096) | 1.97985659 |
| 108 | Sepsis (HP:0100806) | 1.97790913 |
| 109 | Prolonged bleeding time (HP:0003010) | 1.96203044 |
| 110 | Poor head control (HP:0002421) | 1.96184783 |
| 111 | Esophageal varix (HP:0002040) | 1.96063529 |
| 112 | Slow saccadic eye movements (HP:0000514) | 1.95314489 |
| 113 | Mutism (HP:0002300) | 1.94795275 |
| 114 | Bone pain (HP:0002653) | 1.93964494 |
| 115 | Inflammation of the large intestine (HP:0002037) | 1.93419981 |
| 116 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.92385769 |
| 117 | J-shaped sella turcica (HP:0002680) | 1.92358999 |
| 118 | Keratitis (HP:0000491) | 1.91387649 |
| 119 | Eosinophilia (HP:0001880) | 1.91257835 |
| 120 | Nausea (HP:0002018) | 1.89938934 |
| 121 | IgM deficiency (HP:0002850) | 1.89860543 |
| 122 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.89446536 |
| 123 | Restrictive lung disease (HP:0002091) | 1.88832280 |
| 124 | Keratoconjunctivitis (HP:0001096) | 1.88139275 |
| 125 | Pathologic fracture (HP:0002756) | 1.87790283 |
| 126 | Upper motor neuron abnormality (HP:0002127) | 1.87167162 |
| 127 | Nephritis (HP:0000123) | 1.86426558 |
| 128 | Increased CSF protein (HP:0002922) | 1.85278238 |
| 129 | Abnormality of the nasal mucosa (HP:0000433) | 1.84627148 |
| 130 | Menorrhagia (HP:0000132) | 1.84476490 |
| 131 | Purpura (HP:0000979) | 1.83778743 |
| 132 | Nasal polyposis (HP:0100582) | 1.82793639 |
| 133 | Gastrointestinal stroma tumor (HP:0100723) | 1.81544157 |
| 134 | Tetraparesis (HP:0002273) | 1.80477979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 6.00250629 |
| 2 | BLK | 4.10443768 |
| 3 | MAP4K1 | 3.79150230 |
| 4 | MAP3K14 | 3.78394276 |
| 5 | PBK | 3.48842283 |
| 6 | TBK1 | 2.88916290 |
| 7 | IRAK4 | 2.63127538 |
| 8 | TYK2 | 2.58189574 |
| 9 | IRAK3 | 2.37921449 |
| 10 | JAK3 | 2.36442360 |
| 11 | IKBKB | 2.10684370 |
| 12 | PRPF4B | 2.06993190 |
| 13 | TNK2 | 2.00783556 |
| 14 | TAOK1 | 1.90511263 |
| 15 | KIT | 1.86124550 |
| 16 | MAP3K3 | 1.85380803 |
| 17 | MAP3K13 | 1.81068570 |
| 18 | JAK1 | 1.79293072 |
| 19 | TXK | 1.77807702 |
| 20 | ERN1 | 1.75953850 |
| 21 | CSK | 1.72042183 |
| 22 | IKBKE | 1.59983966 |
| 23 | NME2 | 1.49887611 |
| 24 | ZAP70 | 1.49660809 |
| 25 | NEK9 | 1.48333416 |
| 26 | TGFBR2 | 1.44082478 |
| 27 | BMX | 1.39416843 |
| 28 | MARK3 | 1.38882071 |
| 29 | FGR | 1.38624099 |
| 30 | ABL2 | 1.38230993 |
| 31 | SYK | 1.37858224 |
| 32 | STK10 | 1.36787559 |
| 33 | JAK2 | 1.29869443 |
| 34 | HCK | 1.29489406 |
| 35 | MST4 | 1.28182740 |
| 36 | CSF1R | 1.25412341 |
| 37 | TAOK2 | 1.16126821 |
| 38 | BTK | 1.14427974 |
| 39 | CHUK | 1.13994502 |
| 40 | LCK | 1.10930582 |
| 41 | LYN | 1.09613278 |
| 42 | PIM2 | 1.09507662 |
| 43 | EPHB1 | 1.08865474 |
| 44 | TTN | 1.04873316 |
| 45 | FES | 1.04721013 |
| 46 | CDC42BPA | 1.03068131 |
| 47 | TRIB3 | 1.03043383 |
| 48 | BMPR2 | 1.01067233 |
| 49 | MST1R | 1.00169364 |
| 50 | LRRK2 | 0.98900045 |
| 51 | PIM1 | 0.96916438 |
| 52 | GRK7 | 0.95906008 |
| 53 | MARK2 | 0.95706119 |
| 54 | TRPM7 | 0.95506417 |
| 55 | RPS6KA4 | 0.89912801 |
| 56 | TAOK3 | 0.89575844 |
| 57 | YES1 | 0.89547992 |
| 58 | ITK | 0.85634047 |
| 59 | RIPK1 | 0.85333410 |
| 60 | TEC | 0.82561732 |
| 61 | STK4 | 0.82196546 |
| 62 | MATK | 0.80402885 |
| 63 | PRKD2 | 0.79760424 |
| 64 | SIK3 | 0.78506613 |
| 65 | FGFR3 | 0.77886018 |
| 66 | PRKCQ | 0.75280071 |
| 67 | PRKCH | 0.74004571 |
| 68 | ABL1 | 0.71854857 |
| 69 | MAP3K6 | 0.71278958 |
| 70 | MAP3K11 | 0.69284818 |
| 71 | PRKCD | 0.69101842 |
| 72 | CLK1 | 0.68664136 |
| 73 | ERBB3 | 0.66007786 |
| 74 | MAP3K12 | 0.64757054 |
| 75 | SIK2 | 0.63514124 |
| 76 | MAPK12 | 0.63417572 |
| 77 | TESK2 | 0.62866719 |
| 78 | EGFR | 0.61984110 |
| 79 | PDGFRB | 0.61920726 |
| 80 | MAPK7 | 0.61580874 |
| 81 | MAP3K10 | 0.56717496 |
| 82 | PDK1 | 0.56615751 |
| 83 | MOS | 0.56181922 |
| 84 | MAP2K3 | 0.54784110 |
| 85 | SCYL2 | 0.54180652 |
| 86 | SGK3 | 0.53113256 |
| 87 | MAP2K6 | 0.52801329 |
| 88 | PDPK1 | 0.52659753 |
| 89 | PIK3CG | 0.51999989 |
| 90 | PTK2B | 0.51761396 |
| 91 | RPS6KL1 | 0.50279145 |
| 92 | RPS6KC1 | 0.50279145 |
| 93 | IRAK2 | 0.48552866 |
| 94 | MAP2K4 | 0.48314290 |
| 95 | MAP3K7 | 0.47862160 |
| 96 | KSR2 | 0.46871476 |
| 97 | PAK4 | 0.46328074 |
| 98 | HIPK2 | 0.45361866 |
| 99 | STK11 | 0.45322410 |
| 100 | CAMKK2 | 0.44992356 |
| 101 | MAP3K5 | 0.44250198 |
| 102 | CDK6 | 0.44151973 |
| 103 | ACVR1B | 0.42762466 |
| 104 | PTK6 | 0.42340500 |
| 105 | DYRK1B | 0.41754441 |
| 106 | CDK19 | 0.41740590 |
| 107 | GRK6 | 0.41381784 |
| 108 | FYN | 0.41240664 |
| 109 | DAPK2 | 0.39930300 |
| 110 | KSR1 | 0.37460954 |
| 111 | IRAK1 | 0.36345382 |
| 112 | SMG1 | 0.35911603 |
| 113 | PKN2 | 0.35272488 |
| 114 | SIK1 | 0.35105012 |
| 115 | PRKG2 | 0.33940776 |
| 116 | SGK2 | 0.33722159 |
| 117 | RPS6KA6 | 0.33625021 |
| 118 | MAP3K1 | 0.33425822 |
| 119 | DMPK | 0.33242400 |
| 120 | TESK1 | 0.33006307 |
| 121 | DAPK3 | 0.32946277 |
| 122 | MAP3K2 | 0.32284853 |
| 123 | MAPKAPK2 | 0.31942495 |
| 124 | RET | 0.31729197 |
| 125 | FGFR4 | 0.30238482 |
| 126 | RAF1 | 0.30036393 |
| 127 | STK24 | 0.29341516 |
| 128 | ERBB4 | 0.29040936 |
| 129 | EPHA3 | 0.28075336 |
| 130 | CAMK1D | 0.27473447 |
| 131 | STK3 | 0.26886907 |
| 132 | IGF1R | 0.26506286 |
| 133 | RPS6KA2 | 0.26059322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.55351147 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.47339527 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.77362895 |
| 4 | Legionellosis_Homo sapiens_hsa05134 | 2.61992353 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.61811717 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.55071061 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 2.52622275 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.51415645 |
| 9 | * Tuberculosis_Homo sapiens_hsa05152 | 2.45715130 |
| 10 | Malaria_Homo sapiens_hsa05144 | 2.38970176 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.28799649 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.24093643 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.20661277 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.19732055 |
| 15 | Phagosome_Homo sapiens_hsa04145 | 2.15365942 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.96044651 |
| 17 | Salmonella infection_Homo sapiens_hsa05132 | 1.87798441 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.85305769 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.81276808 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.78562528 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.76204065 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.72177475 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.68471737 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.67278947 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.66666187 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.65565311 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.61925629 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.56057513 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.52229183 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51886574 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.50541500 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.50428716 |
| 33 | Asthma_Homo sapiens_hsa05310 | 1.49981997 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.48945288 |
| 35 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.45725810 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.41053044 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.40682419 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.39752623 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39642257 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.31833922 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.29458436 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.27913009 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.20536927 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18000411 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12698620 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05045708 |
| 47 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.03918994 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.00152353 |
| 49 | Amoebiasis_Homo sapiens_hsa05146 | 0.99356269 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97578392 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 0.94685457 |
| 52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.93546010 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.91729329 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.90212656 |
| 55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.89446114 |
| 56 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87040635 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84275015 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.84099341 |
| 59 | Platelet activation_Homo sapiens_hsa04611 | 0.75694441 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.69996217 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69557779 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68710101 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68217199 |
| 64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65433427 |
| 65 | Prion diseases_Homo sapiens_hsa05020 | 0.64643870 |
| 66 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64221053 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64039977 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63577204 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61632199 |
| 70 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.58114775 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55855466 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54375540 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54346404 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46993263 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43687160 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43278774 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43192758 |
| 78 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43087669 |
| 79 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43081643 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42411395 |
| 81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41844887 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.41123666 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41046611 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.40978970 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40383659 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39180854 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38881024 |
| 88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38150003 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36848961 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.33948350 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32964966 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32684648 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31483524 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.31200458 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30250053 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30044135 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29437335 |
| 98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29081538 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.28991067 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.27515229 |
| 101 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.27505413 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27417485 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27251183 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.27131700 |
| 105 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.26354846 |
| 106 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.25964321 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25360419 |
| 108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.22596554 |
| 109 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22044699 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21539142 |
| 111 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.20509722 |
| 112 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.18719528 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | 0.17679785 |
| 114 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.17672309 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.16355792 |
| 116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.16184013 |

